A trial of chemoprophylaxis to prevent tuberculosis in Canadian Inuit (Eskimos) was carried out in Frobisher Bay, Canada during 1971-1974. A completely supervised regimen of isoniazid and ethambutol thrice weekly for 18 months was administered. A 10-year evaluation of 370 treated persons and 217 control subjects demonstrates the sustained value of adequate chemoprophylaxis in reducing the risk of developing active tuberculosis in the 3 groups under study--1, those with a previous episode of active tuberculosis, 2, positive tuberculin reactors with normal chest X-ray and 3, BCG vaccinated individuals with large tuberculin reactions. There were 3 cases of active disease in the treated group, a risk of 0.1% per annum, and 13 cases among the controls, a risk of 1.0% per annum.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0041-3879(84)90059-x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!